Long-term ischaemic and bleeding outcomes after primary percutaneous coronary intervention for ST-elevation myocardial infarction in the elderly

2002 patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary PCI, subdivided by age: < 60 (n=885, 44.2%), 60-79 (n=921, 46.0%), and ≥ 80 years (n=196, 9.7%).

Primary percutaneous coronary intervention (PCI)

Age groups (< 60 years and 60-79 years vs ≥ 80 years)

All-cause mortality, recurrent myocardial infarction (reMI), stent thrombosis, target lesion revascularisation (TLR), bleeding (BARC bleeding ≥ 3), stroke, and major adverse cardiovascular events (MACE, composite of cardiac mortality, reMI, stroke and TLR) at 3-year follow-uphard clinical